首页> 外文期刊>Cancer genetics and cytogenetics >Treatment-related acute myeloid leukemia characterized by t(11;20)(p15;q11) and del(9)(q22). Haimi, Motti); Irit, Avivi (corrected to Avivi, Irit); Nivin, Moustafa (corrected to Moustafa, Nivin); Olfat, Aboleil (corrected to Aboleil, Olfat); Ruth, Ge
【24h】

Treatment-related acute myeloid leukemia characterized by t(11;20)(p15;q11) and del(9)(q22). Haimi, Motti); Irit, Avivi (corrected to Avivi, Irit); Nivin, Moustafa (corrected to Moustafa, Nivin); Olfat, Aboleil (corrected to Aboleil, Olfat); Ruth, Ge

机译:以t(11; 20)(p15; q11)和del(9)(q22)为特征的与治疗有关的急性髓细胞性白血病。 Motti海米); Irit,Avivi(更正为Avivi,Irit); Nivin,Moustafa(已更正为Moustafa,Nivin); Olfat,Aboleil(更正为Aboleil,Olfat);露丝,葛

获取原文
获取原文并翻译 | 示例
       

摘要

Chromosomal aberrations are considered causal events in the process of leukemic transformation. They are frequently associated with therapy-related myelodysplastic syndromes and acute myelogenous leukemia, and are thought to result from exposure to cytotoxic drugs and/or from radiation therapy . Here, we describe for the first time an acute myeloid leukemia (AML) case with two distinct cytogenetic abnormalities, namely t(ll;20)(pl5;qll.2) and del(9q), combined together and conferring a poor prognosis.
机译:染色体畸变被认为是白血病转化过程中的因果事件。它们通常与治疗相关的骨髓增生异常综合症和急性骨髓性白血病有关,并被认为是由于暴露于细胞毒性药物和/或放射治疗所致。在这里,我们首次描述了一个急性髓细胞性白血病(AML)病例,它具有两个明显的细胞遗传学异常,即t(11; 20)(pl5; qll.2)和del(9q),两者合并在一起,预后不良。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号